AUM $42.2MER 0.80%NAV $33.13Holdings 38Inception Nov 2022
Price Chart
Key Statistics
Previous Close
$33.07Day Range
$33.11$33.40
52-Week Range
$25.96$34.88
Avg Volume
3.7KDividend Yield
0.24%Expense Ratio
0.80%AUM
$42.2MShares Outstanding
668.2KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 78.91% |
| Denmark | 14.65% |
| France | 2.66% |
| Netherlands | 2.32% |
| Other | 0.60% |
| Canada | 0.53% |
| Switzerland | 0.33% |
Fund Information
- Issuer
- Harbor
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Nov 16, 2022
- Exchange
- NYSE_ARCA
- Description
- The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). It is non-diversified.
Similar ETFs
The Harbor Health Care ETF (MEDI) (MEDI) is an exchange-traded fund issued by Harbor that launched on Nov 16, 2022. It currently manages $42.2M in assets under management. The fund charges an expense ratio of 0.80%. The fund holds 38 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 61.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | 20.97% | 7,455 | $8.8M |
| 2 | — | ASCENDIS PHARMA A/S | 13.58% | 22,658 | $5.7M |
| 3 | GILD | GILEAD SCIENCES INC | 5.01% | 16,135 | $2.1M |
| 4 | RYTM | RHYTHM PHARMACEUTICALS INC | 4.06% | 16,680 | $1.7M |
| 5 | LEGN | LEGEND BIOTECH CORP-ADR | 3.63% | 65,050 | $1.5M |
| 6 | ABBV | ABBVIE INC | 3.10% | 5,079 | $1.3M |
| 7 | BSX | BOSTON SCIENTIFIC CORP | 2.90% | 28,028 | $1.2M |
| 8 | INSM | INSMED INC | 2.68% | 10,513 | $1.1M |
| 9 | COR | CENCORA INC | 2.63% | 3,634 | $1.1M |
| 10 | ISRG | INTUITIVE SURGICAL INC | 2.60% | 3,300 | $1.1M |
| 11 | RVMD | REVOLUTION MEDICINES INC | 2.50% | 5,583 | $1.1M |
| 12 | MRK | MERCK & CO. INC. | 2.42% | 7,807 | $1.0M |
| 13 | DHR | DANAHER CORP | 2.40% | 5,254 | $1.0M |
| 14 | ABVX | ABIVAX SA-ADR | 2.22% | 7,139 | $936K |
| 15 | ARGX | ARGENX SE - ADR | 2.20% | 1,001 | $926K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.11% | |
| 1W | +0.83% | |
| 1M | -2.15% | |
| 3M | +13.33% | |
| 6M | +6.23% | |
| YTD | +5.54% | |
| 1Y | +20.91% | |
| 3Y | +46.33% | |
| 5Y | +67.75% |
Moving Averages
20-Day MA
$33.77
Below 20-Day MA50-Day MA
$32.02
Above 50-Day MA200-Day MA
$30.97
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$34.88
Current Price
$33.11
52-Week Low
$25.96
$25.96$34.88
Current Yield
0.24%
Annual Dividend
$0.6710
Frequency
1x/year
Last Ex-Date
Dec 19, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $0.0751 | Dec 24, 2025 |
| Dec 20, 2024 | $0.1346 | Dec 26, 2024 |
| Dec 21, 2023 | $0.4613 | Dec 27, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | MEDI | Healthcare(212 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.80% | 0.62% | 0.48% |
| AUM | $42.2M | $1.86B | $724.5M |
| Dividend Yield | 0.24% | 3.66% | 1.61% |
| Avg Volume | 3.7K | 445.6K | 80.0K |
| Holdings | 38 | 147 | 104 |
| Performance | |||
| 1-Month Return | -1.20% | -0.85% | +0.36% |
| 6-Month Return | +11.45% | +12.94% | +10.40% |
| YTD Return | +5.25% | +9.31% | +7.34% |
| 1-Year Return | +11.51% | +14.67% | +12.52% |
Compare with Another ETF
Search for an ETF to compare with MEDI:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.